Financials
- Market Capitalization 619.52 M
- Employee 146
- Founded 2019
- CEO N/A
- Website www.primemedicine.com
- Headquarter Delaware, United States
- FIGI BBG011RT3R55
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.83
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2754 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.86 USD | +0.54% | -13.08% | -4.62% | +50.00% | 641.99 M USD | ||
| 2760 | RGNX REGENXBIO Inc. - Common Stock | 12.12 USD | -1.38% | -22.41% | +71.43% | -9.75% | 626.58 M USD | ||
| 2771 | MDXG MiMedx Group, Inc - Common Stock | 4.29 USD | +2.14% | +2.39% | +16.58% | -32.23% | 638.98 M USD | ||
| 2778 | NGNE Neurogene Inc. - Common Stock | 39.49 USD | +1.05% | +5.19% | +31.63% | +34.23% | 624.02 M USD |